Related references
Note: Only part of the references are listed.The Effect of Proline cis-trans Isomerization on the Folding of the C-Terminal SH2 Domain from p85
Francesca Troilo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Unveiling the Molecular Basis of the Noonan Syndrome-Causing Mutation T42A of SHP2
Angelo Toto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Specificity and regulation of phosphotyrosine signaling through SH2 domains
Michelangelo Marasco et al.
JOURNAL OF STRUCTURAL BIOLOGY-X (2020)
Structural characterization of an on-pathway intermediate and transition state in the folding of the N-terminal SH2 domain from SHP2
Lorenzo Visconti et al.
FEBS JOURNAL (2019)
The kinetics of folding of the NSH2 domain from p85
Lorenzo Visconti et al.
SCIENTIFIC REPORTS (2019)
Mechanism of Folding and Binding of the N-Terminal SH2 Domain from SHP2
Daniela Bonetti et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2018)
Phosphorylated Calmodulin Promotes PI3K Activation by Binding to the SH2 Domains
Mingzhen Zhang et al.
BIOPHYSICAL JOURNAL (2017)
Functions of Shp2 in cancer
Jie Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Structure and function of Gab2 and its role in cancer (Review)
Chen-Bo Ding et al.
MOLECULAR MEDICINE REPORTS (2015)
Targeting SH2 domains in breast cancer
Pietro Morlacchi et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Order and disorder in large multi-site docking proteins of the Gab family-implications for signalling complex formation and inhibitor design strategies
Philip C. Simister et al.
MOLECULAR BIOSYSTEMS (2012)
Overexpression of Grb2-associated Binder 2 in Human Lung Cancer
Xiu-Li Xu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Genome wide analysis of pathogenic SH2 domain mutations
Ilkka Lappalainen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Identification and characterization of protein folding intermediates
Stefano Gianni et al.
BIOPHYSICAL CHEMISTRY (2007)
Germline gain-of-function mutations in SOS1 cause Noonan syndrome
Amy E. Roberts et al.
NATURE GENETICS (2007)
Native state energetics of the Src SH2 domain: Evidence for a partially structured state in the denatured ensemble
David Wildes et al.
PROTEIN SCIENCE (2006)
Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype
Claudio Carta et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
A role for the scaffolding adapter GAB2 in breast cancer
M Bentires-Alj et al.
NATURE MEDICINE (2006)
Kinetic folding mechanism of PDZ2 from PTP-BL
S Gianni et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2005)
Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism
EE Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The kinetic pathway of folding of barnase
F Khan et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes
A Sarkozy et al.
JOURNAL OF MEDICAL GENETICS (2003)
Evidence for sequential barriers and obligatory intermediates in apparent two-state protein folding
IE Sánchez et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Receptor-specific regulation of phosphatidylinositol 3′-kinase activation by the protein tyrosine phosphatase Shp2
SQ Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Regulation of the mitogen-activated protein kinase signaling pathway by SHP2
JM Cunnick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors
CJ Wu et al.
ONCOGENE (2001)
Apparent two-state tendamistat folding is a sequential process along a defined route
A Bachmann et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the Met receptor tyrosine kinase
CR Maroun et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor
JM Cunnick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity
ZQ Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)